HIGHLIGHTS
- who: Shun Takaku et al. from the Department of Microbiology and Immunology, Nippon Medical School, Tokyo, Japan have published the research: Japanese Kampo Medicine Juzentaihoto Improves Antiviral Cellular Immunity in Tumour-Bearing Hosts, in the Journal: Evidence-Based Complementary and Alternative Medicine of 13/08/2022
- what: The authors investigated whether the oral administration of the Japanese traditional herbal (Kampo) medicine juzentaihoto (JTT) plays a role in the improvement of antiviral cellular immunity in tumour-bearing hosts. Several studies of murine tumour models have shown that JTT can prevent cancer occurrence , suppress metastasis to the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.